Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Geron Corp. -- Ignore unavailable to you. Want to Upgrade?

To: BulbaMan who wrote (857)	1/23/1998 12:40:00 AM
From: Haolin Ni	Respond to of 3579

>Geron did not make the details of its diagnostics deal with Boehringer Mannheim public, so I don't see how you can say they got nothing? In fact, Geron's CEO, Ron Eastman, declared at the H&Q conference, that the Boehringer Mannheim deal was done on very favorable terms for Geron.< Hi, Marty, How could you dream the company like GERN did press release the news about a published paper and do every thing on all the TV broadcasting but don't willing to make good details about the good things in the agreement signed with a big company like Boehringer???????? It just tell every one the that the GERN has nothing to say about the real product. Ok, for the sake of the longs, let us all dream in next few months, GERN will announce a big deal so that longs make good profit and shorts can re-run it again as we did it twice already. Sure, GERN will get very favorable terms when it has a real products. Good luck for all!